ENAH and breast cancer: The upregulation of Mena in rat, mouse, and human mammary tumors [5,11,12], use of Mena in the prognostic marker TMEM [12], and Mena's significant role in the regulation of metastatic progression [19,21,23], render Mena an interesting therapeutic target.